comparemela.com

Latest Breaking News On - Quarter for madrigal pharmaceuticals - Page 1 : comparemela.com

Frazier Life Sciences Management L.P. Invests $16.06 Million in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

Frazier Life Sciences Management L.P. bought a new position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 69,406 shares of the biopharmaceutical company’s stock, valued at approximately $16,059,000. Frazier Life Sciences […]

United-states
Piper-sandler
Rebecca-taub
Roberte-waltermire
Securities-exchange-commission
Nasdaq
Frazier-life-sciences-management
Insider-transactions-at-madrigal-pharmaceuticals
Madrigal-pharmaceuticals-stock-performance
Canaccord-genuity-group
Bain-capital-life-sciences-investors
News-ratings-for-madrigal-pharmaceuticals-daily

Paulson & CO. Inc. Grows Stock Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

Paulson & CO. Inc. increased its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 121.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,105,741 shares of the biopharmaceutical company’s stock after purchasing an additional 605,741 shares during the quarter. Madrigal […]

United-states
America
Jamesm-daly
Wolfe-research
Quarter-for-madrigal-pharmaceuticals
Madrigal-pharmaceuticals-company-profile
Exchange-commission
News-ratings-for-madrigal-pharmaceuticals-daily
Madrigal-pharmaceuticals-stock
Global-retirement-partners
Harbor-financial-group

Bain Capital Life Sciences Investors LLC Buys New Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

Bain Capital Life Sciences Investors LLC bought a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 324,619 shares of the biopharmaceutical company’s stock, valued at approximately $75,110,000. Madrigal Pharmaceuticals comprises approximately […]

United-states
America
Roberte-waltermire
Madrigal-pharmaceuticals-inc
Citigroup
Madrigal-pharmaceuticals
Bain-capital-life-sciences-investors
Quarter-for-madrigal-pharmaceuticals
Artisan-partners-limited-partnership
Nasdaq
Vanguard-group-inc

22,500 Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Purchased by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB bought a new position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 22,500 shares of the biopharmaceutical company’s stock, valued at approximately $5,206,000. Several other hedge funds […]

United-states
America
Piper-sandler
Roberte-waltermire
Insider-transactions-at-madrigal-pharmaceuticals
News-ratings-for-madrigal-pharmaceuticals-daily
Vanguard-group-inc
Securities-exchange-commission
Tower-research-capital
Canaccord-genuity-group
Madrigal-pharmaceuticals-inc
Charles-schwab-investment-management-inc

Rebecca Taub Sells 27,506 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock

Rebecca Taub Sells 27,506 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Wellington
New-zealand-general
New-zealand
United-states
American
Rebecca-taub
Canaccord-genuity-group
Madrigal-pharmaceuticals
Citigroup
Perceptive-advisors
Wellington-management-group
Madrigal-pharmaceuticals-inc

vimarsana © 2020. All Rights Reserved.